Lifecore Biomedical Inc (LFCR)

SG&A Expense Growth

-10.39%

Quarterly · Period ending:

LFCR logo

LFCR SG&A Expense Growth

Latest reported-10.39%
LFCR Quarterly SG&A Growth (QoQ) (0.00% → -10.39%)
High-resolution chart · PNG

LFCR sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lifecore Biomedical Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-10.3879%
-0.6775%
-0.9465%
-11.0274%
-9.2274%
-22.2556%
16.9993%
24.1267%
5.4164%
1.4773%
18.5118%
-24.4284%
23.9778%
2.3201%
-57.1723%
33.5875%
76.7723%
-15.396%
-41.315%
98.3895%
-49.4971%
-10.0374%
-1.567%
-3.1678%
0.2937%
10.8494%
-16.6543%
27.9493%
14.3156%
-0.6595%
6.1801%
-4.8381%
6.7497%
-7.9103%
2.826%
-8.9946%
9.3632%
-0.0874%
-1.0089%
30.1811%
-16.824%
5.3432%
12.0992%
5.3797%
3.5079%
12.3039%
-3.717%
5.7586%
0.7061%
0.1043%
37.7494%
-26.5016%
-7.2066%
7.3633%
16.5191%
10.1891%
3.0941%
6.949%
-5.93%
-0.511%
6.357%
7.431%
23.9474%
3.9672%
4.878%
-8.4902%
-3.5662%
14.1103%
-6.6532%
-4.8546%
-24.4954%
28.4056%
13.7768%
-6.7532%
-0.8722%
-5.2284%
-33.6123%
48.6944%
-34.1925%
3.5302%
0.5731%
15.7044%
4.1962%
-3.6375%
3.5654%
10.6233%
-5.1861%
0.6748%
7.8529%
-4.7784%
-20.0612%
5.1349%
5.2088%
-1.2894%
-12.1644%
5.4401%
41.7851%
-28.9364%
-7.6543%
-10.6727%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.